Remedy H2: Estimate-miss but strong 2020 expected
Research Note
2020-02-14
12:35
Revenue and EBIT were well below our estimates for the second half of 2019. We make comments on expected future royalty-payments for Control, the outlook for 2020 and the revealed price-tag on the peer-company Insomniac.
TO
KL
Tomas Otterbeck
Kristoffer Lindström
Disclosures and disclaimers